JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹28 Cr | ₹8.12 Cr | ₹17 Cr | ₹9.27 Cr | ₹19 Cr |
What is the latest Cash Flow from Operating Activities ratio of JENBURKT PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹28 Cr |
Mar2024 | ₹8.12 Cr |
Mar2023 | ₹17 Cr |
Mar2022 | ₹9.27 Cr |
Mar2021 | ₹19 Cr |
How is Cash Flow from Operating Activities of JENBURKT PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹28 Cr | 243.50 | |
Mar2024 | ₹8.12 Cr | -52.36 | |
Mar2023 | ₹17 Cr | 83.93 | |
Mar2022 | ₹9.27 Cr | -52.35 | |
Mar2021 | ₹19 Cr | - |
Compare Cash Flow from Operating Activities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹590.2 Cr | -3.3% | 4.6% | 56.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -3.3% |
4.6% |
56.4% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses